Condensed Consolidated Interim Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (11,084)	$ (7,782)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	1,046	1,118
Equity based compensation	2,396	1,227
Change in fair value of derivative liability	2,532
Accretion of lease liability	612	412
Write-off of fixed asset from terminated lease	799
Write-off of deposit	80
Accretion of contingent consideration	124
Accrued interest on convertible debentures	590	861
Amortization of loan discount upon conversion of debt to equity	2,915
Deferred taxes	632
Accrued interest on notes payable	1,097	37
Accrued interest on lease receivable		(163)
Changes in operating assets and liabilities	1,075	589
NET CASH PROVIDED BY (USED IN) CONTINUED OPERATING ACTIVITIES	2,814	(3,701)
Net cash provided by discontinued operation activities		203
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	2,814	(3,498)
CASH FLOWS FROM INVESTING ACTIVITIES
Notes receivable repayments	63	141
Issuance on notes receivable		(848)
Sale of dispensary and interests in cannabis licenses	1,093	5,291
Purchases of property and equipment	(7,186)	(4,057)
NET CASH PROVIDED BY (USED IN) CONTINUED INVESTING ACTIVITIES	(6,030)	527
Net cash used in discontinued investing activities		632
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(6,030)	1,159
CASH FLOWS FROM FINANCING ACTIVITIES
Notes payable received, net of costs	411	1,192
Issuance of convertible notes		2,810
Proceeds from the exercise of warrants	1,563
Proceeds from the exercise of stock options	871
Repayment of notes payable	(755)	(516)
NET CASH PROVIDED BY CONTINUED FINANCING ACTIVITIES	2,090	3,486
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,090	3,486
NET INCREASE (DECREASE) IN CASH	(1,126)	1,147
CASH, BEGINNING OF PERIOD	18,932	8,141
CASH, END OF PERIOD	$ 17,806	$ 9,288